| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.068 | 0.05 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | -0.072 | 0.05 |
| mRNA | GNF-2 | GDSC1000 | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | 0.064 | 0.05 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |